About Agios (AGIO)
Agios Pharmaceuticals, Inc is a clinical-stage biopharmaceutical company. The Company's lead product candidate in its genetically defined disease (GDD) portfolio, mitapivat, is an activator for the treatment of hemolytic anemias. The Company’s clinic... Read more
- USD36.71
- USD38.03
- USD36.60
- USD62.58
- 5.70%
- 37M
- 165.09k
- 579.84k
- 2.1B
- 23.42
- -11.90%
Stock News
2 hours ago
Foresight: Eye-Net, in Collaboration with Orange’s Mobile Application, Achieves 99% Detection Rate in French Urban Mobility Trials
Yahoo
2 hours ago
This early-warning indicator is telling the stock market that a recession is more likely
MarketWatch
6 hours ago
What If Mistras Isn't As Broken As It Looks?
SeekingAlpha
6 hours ago
Boeing: Leadership Changes And A Warning For The Bulls
SeekingAlpha
Unlock More Stock Analysis & Reports
Access detailed stock analysis from LSEG including analyst price target estimates.
